BIOGEN INT NEUROSCIENCE GMBH has a total of 73 patent applications. It decreased the IP activity by 11.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are IMMUTEP SAS, BIOGEN INTERNAT NEUROSCIENCE GMBH and PANIMA PHARMACEUTICALS AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | EPO (European Patent Office) | 10 | |
#3 | Australia | 8 | |
#4 | Japan | 5 | |
#5 | Israel | 4 | |
#6 | Republic of Korea | 4 | |
#7 | Mexico | 4 | |
#8 | Brazil | 3 | |
#9 | Canada | 3 | |
#10 | Hungary | 3 | |
#11 | WIPO (World Intellectual Property Organization) | 3 | |
#12 | China | 2 | |
#13 | EAPO (Eurasian Patent Organization) | 2 | |
#14 | Hong Kong | 2 | |
#15 | Singapore | 2 | |
#16 | Jordan | 1 | |
#17 | Malaysia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Grimm Jan | 36 |
#2 | Hock Christoph | 24 |
#3 | Nitsch Roger | 23 |
#4 | Weihofen Andreas | 17 |
#5 | Williams Leslie Lugene | 12 |
#6 | Sevigny Jeffrey Joseph | 12 |
#7 | Weinreb Paul | 12 |
#8 | Baeriswyl Jean-Luc | 9 |
#9 | Muralidharan Kumar Kandadi | 9 |
#10 | Penner Natasha | 9 |
Publication | Filing date | Title |
---|---|---|
BR112019020335A2 | compositions and methods for treating synucleinopathies | |
EP3464350A1 | Methods for treating alzheimer's disease | |
US2019079077A1 | Antibody-dependent cell-mediated phagocytosis assay for reliably measuring uptake of aggregated proteins | |
CA2967897A1 | Methods for treating alzheimer's disease | |
AU2012327211A1 | TDP-43 specific binding molecules | |
HUE041391T2 | Anti-alpha synuclein binding molecules | |
EP2949666A1 | Human anti-alpha-synuclein antibodies |